Effects of dietary interventions focused on adding base in the management of metabolic acidosis in adults with chronic kidney disease: A protocol for systematic review and meta-analysis of randomized clinical trials

Background

Chronic Kidney Disease (CKD) is a progressive condition and is recognized as a leading health concern worldwide (1, 2). The condition is categorized into 5 stages based on Glomerular Filtration Rate (GFR); Early stages are asymptomatic, but can progress rapidly to kidney failure within months in some individuals (3). CKD is associated with increased risk of cardiovascular disease (CVD), kidney failure requiring renal replacement therapy, poor quality of life, and mortality (4). The global prevalence of CKD has been estimated 13.4% (5). According to a cross-sectional study, the overall estimated prevalence of stage 3 to 5 CKD in the Canadian population was 71.9 per 1000 individuals, from 2010 to 2015 (6).

Kidneys play a crucial role in maintaining acid-base balance by reabsorbing bicarbonate from filtrate and excreting acid and ammonia into urine (7). The cause of metabolic acidosis in CKD is the inability of kidneys to excrete enough acid, leading to a positive H⁺ balance and low CO2 concentrations (13). As kidney function declines metabolic acidosis becomes a common complication in people with CKD and its prevalence increases with the decline in GFR, especially when GFR levels fall below 40 ml/min/1.73m² (8, 9). Although metabolic acidosis is usually mild to moderate in CKD, the condition can impair different organ systems, and contribute to increased morbidity and mortality (10, 11). Augmentation of inflammation, bone disease exacerbation, muscle wasting, and acceleration of CKD progression are among adverse effects related to metabolic acidosis (12).

Sodium bicarbonate (NaHCO3) is an alkali salt commonly used in the treatment of metabolic acidosis (14), which may improve endothelial function and muscle mass and delay kidney failure (15). However, oral alkali therapy has been related to a number of side effects including gastric discomfort and bloating, with many people having difficulty tolerating higher doses (16). Furthermore, concerns have been raised about sodium retention, volume overload and exacerbating pre-existing hypertension when sodium bicarbonate is used (17).

Daily acid load is mostly determined by the metabolism of dietary constituents into base or acid production. Sulfur containing amino acids (abundant in animal sources of protein) lead to H⁺ production while fruit and vegetables are base producing (9). Dietary H⁺ reduction is hence another strategy in the management of CKD-related metabolic acidosis, by reducing the intake of acid producing components (such as animal proteins) as opposed to adding base by increasing fruit and vegetables consumption (18).

Recent studies have reported that treating metabolic acidosis with fruit and vegetables might be as effective as alkali therapy in improving disease state by modifying HCO3 concentrations, while also reducing blood pressure and preserving eGFR with no concerns regarding adverse events (19, 20). One clinical trial has even shown that fruit and vegetables treatment not only improved metabolic acidosis, but also reduced CVD risk better than NaHCO3 (21). There is a need to integrate existing findings on the effects of adding base through fruit and vegetables consumption in the management of CKD-related metabolic acidosis. This proposed systematic review will evaluate the efficacy and safety of using fruit and vegetables to manage metabolic acidosis, as well as look at patients’ compliance and tolerability, looking to identify limitations in the current literature and set directions for future research.(23)

Methods

Discussion

Metabolic acidosis is of the most common consequences of CKD, with a leading role in CKD-related morbidity and mortality (31). Data from both observational and interventional studies has shown that correction of metabolic acidosis by NaHCO3 or diets rich in base producing fruit and vegetables may have the ability to slow the rate of decline in kidney function (32). Patients on Na⁺-based alkali therapy are at an increased risk of worsened hypertension or volume control, especially at lower eGFR (33). On the other hand, the usual dietary habits of developed countries often result in diets with increased production of acid equivalents (34). Therefore, dietary interventions targeting the addition of base producing fruit and vegetables may be more appropriate than alkaline therapy in the management of CKD induced metabolic acidosis. Some small single center trials have been conducted on the effects of fruit and vegetables consumption on different outcomes related to kidney function, in different stages of CKD. Some review articles have included effects of dietary interventions in the management of CKD (34, 35) which have provided general information in the topic. To the best of our knowledge, our study will be the first to systematically review data from randomized studies aiming at evaluating the effects of adding dietary base equivalents via fruit and vegetables consumption in the management of CKD-related metabolic acidosis. Our study is not obstacle-free. The number of studies meeting our criteria might be few and heterogeneity might arise due to different settings and clinical stages. Nevertheless, we have prepared a plan for prespecified subgroup analysis based on dietary interventions (adding base vs. reducing acid), type of intervention (providing food vs. recommendation only), sex, diabetes comorbidity, CKD stages and region. The findings of this study will be useful to guide clinical practice regarding the use of base producing fruit and vegetables as an alternative option to oral alkali therapy. Furthermore, this study will find limitations of the current literature and inform the design of future research in this area

Supplementary information

Supplementary file 1: search strategy Supplementary file 2: PRISMA-P 2015 checklist

Authors contribution

SM drafted the review protocol manuscript. NA is a health sciences librarian who developed the search strategy based on input from DM, RM, AMAS, RR NT and SM. AAB and RB provided content expertise in knowledge synthesis and meta-analysis. NT provided content expertise in chronic kidney disease. RM and DM are content experts in nutritional interventions. Each author reviewed and made substantial contributions to this manuscript. All authors have read and approved the final manuscript.

Funding

This study is funded by University of Manitoba and Seven Oaks Chronic Disease Innovation Centre.

Availability of data and material

The Endnote database, as well as final extraction sheets and data regarding risk of bias assessment will be available upon request.

Competing interest

None

Ethics approval and consent to participate

Not applicable

Consent for publication

Not applicable